Selected research
Market Outlook & Growth Opportunities
Global Next Generation Sequencing (NGS) Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Next Generation Sequencing (NGS) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Next Generation Sequencing (NGS) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Next Generation Sequencing (NGS) Service market include CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar and 454 Life Sciences Corporation (Roche), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Next Generation Sequencing (NGS) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Next Generation Sequencing (NGS) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Next Generation Sequencing (NGS) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next Generation Sequencing (NGS) Service market.
Next Generation Sequencing (NGS) Service Segment by Company
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
Next Generation Sequencing (NGS) Service Segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Next Generation Sequencing (NGS) Service Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Next Generation Sequencing (NGS) Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Next Generation Sequencing (NGS) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Next Generation Sequencing (NGS) Service key companies, revenue, market share, and recent developments.
3. To split the Next Generation Sequencing (NGS) Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Next Generation Sequencing (NGS) Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Next Generation Sequencing (NGS) Service significant trends, drivers, influence factors in global and regions.
6. To analyze Next Generation Sequencing (NGS) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation Sequencing (NGS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next Generation Sequencing (NGS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation Sequencing (NGS) Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next Generation Sequencing (NGS) Service industry.
Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Next Generation Sequencing (NGS) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Next Generation Sequencing (NGS) Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
Applications
- Whole-genome Sequencing
- Exome Sequencing
- Targeted Resequencing
- De Novo Sequencing
- RNA Sequencing
- ChIP Sequencing
- Methyl Sequencing
- Others
Companies covered
- CLC Bio
- GATC biotech AG
- Macrogen
- BGI (Beijing Genomics Institute)
- Illumina
- Life Technology Corporation
- EMC Corporation
- Dnastar
- 454 Life Sciences Corporation (Roche)
- Agilent Technologies
- Biomatters, Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Next Generation Sequencing (NGS) Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Next Generation Sequencing (NGS) Service Market Dynamics
- 2.1 Next Generation Sequencing (NGS) Service Industry Trends
- 2.2 Next Generation Sequencing (NGS) Service Industry Drivers
- 2.3 Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges
- 2.4 Next Generation Sequencing (NGS) Service Industry Restraints
3 Next Generation Sequencing (NGS) Service Market by Company
- 3.1 Global Next Generation Sequencing (NGS) Service Company Revenue Ranking in 2025
- 3.2 Global Next Generation Sequencing (NGS) Service Revenue by Company (2021-2026)
- 3.3 Global Next Generation Sequencing (NGS) Service Company Ranking (2024-2026)
- 3.4 Global Next Generation Sequencing (NGS) Service Company Manufacturing Base and Headquarters
- 3.5 Global Next Generation Sequencing (NGS) Service Company Product Type and Application
- 3.6 Global Next Generation Sequencing (NGS) Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Next Generation Sequencing (NGS) Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Next Generation Sequencing (NGS) Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Next Generation Sequencing (NGS) Service Market by Type
- 4.1 Next Generation Sequencing (NGS) Service Type Introduction
- 4.1.1 Targeted Sequencing & Resequencing
- 4.1.2 Whole Genome Sequencing
- 4.1.3 Whole Exome Sequencing
- 4.2 Global Next Generation Sequencing (NGS) Service Sales Value by Type
- 4.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021-2032)
- 4.2.3 Global Next Generation Sequencing (NGS) Service Sales Value Share by Type (2021-2032)
5 Next Generation Sequencing (NGS) Service Market by Application
- 5.1 Next Generation Sequencing (NGS) Service Application Introduction
- 5.1.1 Whole-genome Sequencing
- 5.1.2 Exome Sequencing
- 5.1.3 Targeted Resequencing
- 5.1.4 De Novo Sequencing
- 5.1.5 RNA Sequencing
- 5.1.6 ChIP Sequencing
- 5.1.7 Methyl Sequencing
- 5.1.8 Others
- 5.2 Global Next Generation Sequencing (NGS) Service Sales Value by Application
- 5.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021-2032)
- 5.2.3 Global Next Generation Sequencing (NGS) Service Sales Value Share by Application (2021-2032)
6 Next Generation Sequencing (NGS) Service Regional Value Analysis
- 6.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2021-2032)
- 6.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region: 2021-2026
- 6.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
- 6.3.2 North America Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
- 6.4.2 Europe Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
- 6.6.2 South America Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
7 Next Generation Sequencing (NGS) Service Country-level Value Analysis
- 7.1 Global Next Generation Sequencing (NGS) Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2021-2032)
- 7.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2021-2026)
- 7.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 CLC Bio
- 8.1.1 CLC Bio Company Information
- 8.1.2 CLC Bio Business Overview
- 8.1.3 CLC Bio Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.1.4 CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio
- 8.1.5 CLC Bio Recent Developments
- 8.2 GATC biotech AG
- 8.2.1 GATC biotech AG Company Information
- 8.2.2 GATC biotech AG Business Overview
- 8.2.3 GATC biotech AG Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.2.4 GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio
- 8.2.5 GATC biotech AG Recent Developments
- 8.3 Macrogen
- 8.3.1 Macrogen Company Information
- 8.3.2 Macrogen Business Overview
- 8.3.3 Macrogen Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Macrogen Next Generation Sequencing (NGS) Service Product Portfolio
- 8.3.5 Macrogen Recent Developments
- 8.4 BGI (Beijing Genomics Institute)
- 8.4.1 BGI (Beijing Genomics Institute) Company Information
- 8.4.2 BGI (Beijing Genomics Institute) Business Overview
- 8.4.3 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.4.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio
- 8.4.5 BGI (Beijing Genomics Institute) Recent Developments
- 8.5 Illumina
- 8.5.1 Illumina Company Information
- 8.5.2 Illumina Business Overview
- 8.5.3 Illumina Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Illumina Next Generation Sequencing (NGS) Service Product Portfolio
- 8.5.5 Illumina Recent Developments
- 8.6 Life Technology Corporation
- 8.6.1 Life Technology Corporation Company Information
- 8.6.2 Life Technology Corporation Business Overview
- 8.6.3 Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 8.6.5 Life Technology Corporation Recent Developments
- 8.7 EMC Corporation
- 8.7.1 EMC Corporation Company Information
- 8.7.2 EMC Corporation Business Overview
- 8.7.3 EMC Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.7.4 EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 8.7.5 EMC Corporation Recent Developments
- 8.8 Dnastar
- 8.8.1 Dnastar Company Information
- 8.8.2 Dnastar Business Overview
- 8.8.3 Dnastar Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Dnastar Next Generation Sequencing (NGS) Service Product Portfolio
- 8.8.5 Dnastar Recent Developments
- 8.9 454 Life Sciences Corporation (Roche)
- 8.9.1 454 Life Sciences Corporation (Roche) Company Information
- 8.9.2 454 Life Sciences Corporation (Roche) Business Overview
- 8.9.3 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.9.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio
- 8.9.5 454 Life Sciences Corporation (Roche) Recent Developments
- 8.10 Agilent Technologies
- 8.10.1 Agilent Technologies Company Information
- 8.10.2 Agilent Technologies Business Overview
- 8.10.3 Agilent Technologies Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio
- 8.10.5 Agilent Technologies Recent Developments
- 8.11 Biomatters, Ltd
- 8.11.1 Biomatters, Ltd Company Information
- 8.11.2 Biomatters, Ltd Business Overview
- 8.11.3 Biomatters, Ltd Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio
- 8.11.5 Biomatters, Ltd Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst